Document is current
Any future updates will be listed below
-
Authors
Tawe, Leabaneng
Choga, Wonderful T.
Paganotti, Giacomo M.
Bareng, Ontlametse T.
Ntereke, Tlhalefo D.
Ramatlho, Pleasure
Ditshwanelo, Doreen
Gaseitsiwe, Simani
Kasvosve, Ishmael
Ramogola-Masire, Doreen
Orang’o, Omenge E.
Robertson, Erle
Zetola, Nicola
Moyo, Sikhulile
Grover, Surbhi
Ermel, Aaron C.
-
Funding
Funding for this research was provided by:
Sub-Saharan African Network for TB/HIV Research Excellence (DEL-15-006, DEL-15-006, DEL-15-006)
Penn Center for AIDS Research (5-P30-AI- 045008-17)
Sub-Saharan African Collaborative HIV and Cancer Consortia-U54 (1U54 CA190158-01, 1U54 CA190158-01)
- License Information
-
More Information
Article History
Received: 29 June 2021
Accepted: 14 January 2022
First Online: 27 January 2022
Declarations
:
: The research was approved by Institutional Review Board (IRB) at the University of Botswana (RES/IRB/1636), the Human Resource Development Council at the Botswana Ministry of Health and Wellness and the University of Pennsylvania’s IRB (HPDME 13/18/1 X1). Approval for the study was also granted by the Institutional Review Board at Indiana University School of Medicine, and by the Institutional Research and Ethics Committee at Moi University Teaching and Referral Hospital (IREC/2011/174). Material Transfer Agreement (MTA) was obtained from Institutional Review Board at Indiana University School of Medicine and the Institutional Review Board (IRB) at the University of Botswana. Written informed consent for participation was not required for this study in accordance with the national legislation and the institutional requirements. The procedure of the study was in accordance with the Good Clinical Practice Guidelines and the ethical standards of the Helsinki Declaration.
: Not applicable.
: There are no relevant conflicts of interest for the authors of the study.
